Connect with us

Technology

BioInnovation Institute welcomes twelve new companies to its Venture Lab program

Published

on

COPENHAGEN, Denmark, Feb. 29, 2024 /PRNewswire/ — BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today announces that twelve new companies have entered its Venture Lab acceleration program for early-stage companies. The cohort is strategically aligned with BII’s focus on supporting innovative early-stage start-ups that can improve human and planetary health. 

The 12-month Venture Lab program is designed to support start-up companies with business acceleration, scientific, and team development, and provides a founder-friendly convertible loan of EUR 500,000 (approximately 4M DKK) plus access to labs and offices at the BII in Copenhagen. In becoming a part of the Venture Lab program, the early-stage companies also get an exclusive opportunity to apply for EUR 1.3M in follow-up funding through BII’s Venture House program.

Bobby Soni, Chief Business Officer at BioInnovation Institute, said: “Working across the planetary, therapeutics, women’s health, health tech and quantum industries, these twelve start-ups have demonstrated the drive and tenacity that align with BII’s mission in creating innovative solutions to address current challenges in these sectors. We once again look forward to supporting these start-ups in bringing their innovations into fruition by providing our knowledge, network, funding, and infrastructure to build successful companies.”

Each start-up will be supported in undertaking the necessary steps to reach initial proof-of-concept, to make a business plan and to set up a team. Assisted by a dedicated scientific advisor, a leadership coach and a BII business development expert, the new ventures will be guided in developing a detailed milestone plan and will be assisted in overcoming the challenges of growing a business allowing them to progress rapidly towards the market.

The new companies BII has accepted into the Venture Lab acceleration program are:

Planetary Health

CAMBIOTICS is developing precision probiotics for PFAS detoxification.SNL Biosolutions has developed an innovative technology platform that can produce fermentation-based oils at scale and prevent deforestation. The technology can be used to produce a wide range of products spanning from food ingredients to sustainable aviation fuel.SymbioMATCH produces effective biofertilizers tailored to each soil condition and legume crop.

Therapeutics

PreTT is a pioneer in advancing pre-targeted radioimmunotherapies to improve the lives of millions of cancer patients.Polyceutix is transforming cancer treatment by unleashing the full power of the immune system exactly where it is needed.

Women’s Health

Pharmista Technologies is developing a reusable pregnancy test which will be the start of a new generation of reusable diagnostics.oasicare is on a mission to improve women’s health during childbirth and postpartum on a global scale. The Company’s first solution is a medical device preventing the risk of birth tears.

Health Tech

Zeta Diagnostics is developing a portable audio device that allows physicians to detect middle ear problems before they become permanent complications.Glaze Life Sciences is developing a non-invasive device to measure blood glucose to improve the everyday life of people living with diabetes.

Quantum

DiaSense is developing a quantum diamond-magnetic microscope to be used by neuroscientists to diagnose diseases and find cures.Sqale is revolutionizing biomanufacturing by using quantum technologies.Alea Quantum Technologies has developed a quantum random number generator that will enable safe and trusted data sharing in the post-quantum era.

Since its inception in 2018, BII has supported 100 start-ups and projects with EUR 89 million alongside the venture capital, industry and business expertise it provides to help them accelerate to the next level.  In total, BII’s start-ups have raised over EUR 428 million in external funding from both local and international investors.  Recent company successes include Embark LaboratoriesAdcendo, Stipe Therapeutics, Twelve Bio, Octarine Bio, and Cirqle Biomedical.

Read more about the Venture Lab program 

About the BioInnovation Institute Foundation:

At BioInnovation Institute (BII), we accelerate world-class life science start-up innovation for the benefit of people and society. As a non-profit institute, BII operates the company creation programs, Bio Studio, Venture Lab and Venture House, to support life science start-ups with knowledge, network, infrastructure and funding of up to 3M EUR per projects and 1,8 M EUR per start-up. With our expertise, network, funding, and infrastructure, we empower startups to succeed and believe in the transformative power of life science innovation. Read more on www.bioinnovationinstitute.com 

View original content:https://www.prnewswire.co.uk/news-releases/bioinnovation-institute-welcomes-twelve-new-companies-to-its-venture-lab-program-302074565.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bill Faust Named Consulting Magazine Top Consultant of the Year in Industry Specialization

Published

on

By

Impact Advisors Leader Recognized for Expertise in Healthcare IT Implementation

CHICAGO, April 22, 2026 /PRNewswire-PRWeb/ — Impact Advisors, a leading healthcare management consulting firm, is proud to announce that Bill Faust, Managing Director, has been named a Top Consultant of the Year by Consulting Magazine in the category of Industry Specialization. This prestigious award honors consultants who demonstrate deep domain expertise and deliver exceptional value to clients within their field.

“Bill’s recognition as a Top Consultant of the Year is a testament to his deep industry expertise and unwavering commitment to client success.” -Andy Smith, managing partner and co-founder of Impact Advisors

Faust brings more than 28 years of healthcare IT experience, with a distinguished track record leading large-scale, complex implementations for both ambulatory and acute care organizations. Over the past 25 years, he has held progressive leadership roles supporting major Epic and Oracle initiatives, helping healthcare systems successfully navigate digital transformation and achieve measurable outcomes.

In his role at Impact Advisors, Faust leads the firm’s EHR Implementation & Support practice, where he is responsible for driving strategy, delivery excellence, and client success across some of the most complex healthcare IT programs in the country. His ability to combine deep technical knowledge with strong executive communication has enabled him to build trusted relationships with clients and vendor partners alike.

“Bill’s recognition as a Top Consultant of the Year is a testament to his deep industry expertise and unwavering commitment to client success,” said Andy Smith, managing partner and co-founder of Impact Advisors. “He consistently delivers high-impact results for our clients while helping advance the healthcare industry through his thoughtful, strategic leadership. Bill joined our team as our ninth colleague, and we’re fortunate to have had his guidance for all these years.”

Consulting Magazine’s Top Consultants awards recognize outstanding professionals who have made significant contributions to the consulting profession and their clients. The Industry Specialization category specifically highlights consultants who have demonstrated exceptional depth of knowledge and impact within a defined sector.

Faust’s recognition underscores Impact Advisors’ continued leadership in healthcare consulting and its commitment to delivering innovative, high-quality solutions that improve patient care and operational performance.

About Impact Advisors

Impact Advisors is a leading healthcare management consulting firm offering a comprehensive suite of technology-enabled performance improvement solutions that deliver measurable and sustainable value for clients. Our commitment to excellence has earned Best in KLAS® recognition for 19 consecutive years, and our distinctive culture has been named a “Best Place to Work” by Modern Healthcare for 16 years. Learn more at www.impact-advisors.com.

Media Contact

Catherine Povalitis, Impact Advisors, 1 815-282-9976, cpovalitis@chartwellagency.com, https://www.impact-advisors.com/

View original content to download multimedia:https://www.prweb.com/releases/bill-faust-named-consulting-magazine-top-consultant-of-the-year-in-industry-specialization-302750670.html

SOURCE Impact Advisors

Continue Reading

Technology

Hewlett Foundation President: Philanthropy Must Bridge AI Governance Gap Between Washington and Silicon Valley

Published

on

By

Amber D. Miller makes the case for philanthropy and civil society to protect critical infrastructure and deliver broad benefits.

SAN FRANCISCO, April 22, 2026 /PRNewswire/ — As conversations between Washington and Silicon Valley about AI policy grow more contentious, Hewlett Foundation President Amber D. Miller calls on philanthropy to step up. In a new op-ed published by RealClearPolicy, Miller argues that governments and industry can’t close America’s AI governance gap alone, but independent institutions and philanthropy can help bridge the divide.

Drawing on her background as a physicist, Miller advocates for a practical, non-ideological approach to AI governance focused on protecting critical infrastructure, preventing strategic technological surprise, and keeping people safe while fostering innovation.

“Much of America’s critical infrastructure is highly distributed and deeply vulnerable, and its protection is dangerously under-resourced. The Hewlett Foundation wants to maximize the public benefits of emerging technologies while proactively mitigating their risks.”

To address these challenges, the Hewlett Foundation recently announced $10 million in exploratory grants to support the security of emerging technologies, including AI, biotechnology, and quantum computing.

Major grants were awarded to Stanford University’s Hoover Institution for its Tech Futures Lab, which focuses on anticipating technological surprises and enhancing U.S. resilience and Vanderbilt University’s Institute for National Security for its Wicked Problems Lab, which is building defenses against synthetic information warfare like deepfakes.

Former Secretary of State Condoleezza Rice, the director of the Hoover Institution, highlighted the importance of integrating security into innovation: “Innovation is key to national security…. Innovators will have more valuable, more marketable products if they build security into it at the front end.”

Other grantees include, the AI Now Institute, Aspen Institute, Atlantic Council, Carnegie Endowment for International Peace, Council on Foreign Relations, Georgetown University, Global Network Initiative, Institute for Security and Technology, Observer Research Foundation America, RAND, and Sentinel Bio.

Miller calls on others to join Hewlett, writing, “America has led every major technological era of the modern age, helping usher in significant discoveries that have benefited communities both here and around the world. Whether it continues to lead will depend not only on breakthroughs in labs, but on whether innovation earns public trust and delivers broad benefits. Philanthropy, with its long-term focus and commitment to charitable good, can do much to help.”

For more, read the op-ed and grant announcement: https://hewlett.org/americas-ai-governance-gap-needs-independent-oversight/ 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hewlett-foundation-president-philanthropy-must-bridge-ai-governance-gap-between-washington-and-silicon-valley-302750841.html

SOURCE The Hewlett Foundation

Continue Reading

Technology

Hyperscale Data Sees Rising Demand Across Defense Portfolio Amid Heightened Global Activity

Published

on

By

LAS VEGAS, April 22, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI”) data center company anchored by Bitcoin (“Hyperscale Data” or the “Company”), today announced that its wholly-owned subsidiary Gresham Worldwide, Inc., which is expected to be merged with another wholly owned subsidiary of the Company called Ballista Group, Inc., and the related party TurnOnGreen, Inc. (the “Defense Systems Group”), are actively supporting the expected increase in global defense production through its integrated portfolio of high-performance defense engineering and manufacturing subsidiaries.

The Defense Systems Group operates as an integrated engineering and manufacturing platform serving defense, aerospace, and industrial markets, delivering mission-critical electronics, radio frequency (“RF”) systems, power platforms, and advanced control technologies across the full lifecycle, from design through long-term sustainment. 

Recent global events, including but not limited to the ongoing conflicts in the Middle East and Ukraine, have contributed to increased demand signals across defense and mission-critical infrastructure supply chains. Management of the Defense Systems Group has observed a measurable uptick in inbound inquiries, program discussions and order flow across the group’s core product lines, particularly in:

RF and microwave systems supporting radar and electronic warfare;Power systems and ruggedized electronics for defense and mobility platforms; andTest, validation, and simulation technologies for mission-critical environments.

“These are environments where failure is not an option,” said Milton “Todd” Ault III, Executive Chairman of Hyperscale Data. He added that “The Defense Systems Group was assembled to deliver precision-engineered solutions for exactly these mission-critical applications, and we are seeing that demand accelerate in real time.” Further, Mr. Ault stated that “The group’s combination of deep engineering expertise, advanced manufacturing capabilities, and a global operational footprint provides a strong foundation to support long-term growth across defense, aerospace, and other mission-critical technology sectors.

The Defense Systems Group platform supports highly regulated and security-sensitive programs, operating under certifications including ISO, AS9100, and ITAR compliance, and serves customers across defense, aerospace, and critical infrastructure sectors globally. 

“As geopolitical conditions evolve, supply chains for advanced electronics and defense-related technologies are becoming increasingly constrained,” stated William Horne, Chief Executive Officer of Hyperscale Data. “The Defense Systems Group collectively provides a vertically integrated platform supporting advanced defense electronics, power systems, RF and microwave components, and precision-engineered subsystems, positioning the organization to support current and emerging demand across multiple strategic defense programs.”

While the Company continues to monitor global developments, management of the Defense Systems Group believes that sustained demand for mission-critical electronics, ruggedized power systems, and secure infrastructure technologies could present potential opportunities across the Defense Systems Group.

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center at which it mines digital assets and offers colocation and hosting services for the emerging AI ecosystems and other industries. Hyperscale Data’s other wholly owned subsidiary, Ault Capital Group, Inc. (“ACG”), is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.

Hyperscale Data currently expects the divestiture of ACG (the “Divestiture”) to occur in the second quarter of 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive, medical/biopharma and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”) to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the “ACG Shares”). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at hyperscaledata.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperscale-data-sees-rising-demand-across-defense-portfolio-amid-heightened-global-activity-302750842.html

SOURCE Hyperscale Data Inc.

Continue Reading

Trending